Eiger Biopharmaceuticals, Inc.
Annual report (10-K)
Latest 10-K/A filed Apr 29, 2024. Sentiment + YoY language diff vs prior year. Read sections →
Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.
Recent 8-K announcements
Per-item disclosure feed. Item 2.02 is the earnings release.
Top insiders
Most active reporters at Eiger Biopharmaceuticals, Inc.
| Name | Roles | Filings |
|---|---|---|
| Mayer Eldon C. III | Officer | 6 |
| Apelian David | OfficerDirector | 3 |
| Dietz Thomas John | Director | 3 |
| Murray Christine | Director | 3 |
| Atkisson Erik | Officer | 2 |
Showing 1-5 of 16
All filings
33 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|